No products in the cart.
Clodronate Disodium Capsules
$2.00
Clodronate Disodium Capsules are a bisphosphonate medication used to inhibit osteoclast-mediated bone resorption. Manufactured by Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. and approved by China’s NMPA (National Medical Products Administration) under approval number H19980041.
Description
Clodronate Disodium Capsules Product Specifications
| Attribute | Information |
|---|---|
| Product Name | Clodronate Disodium Capsules (Baiyunshan/Dewei) |
| Formulation | Capsule, 0.4g × 10 capsules |
| Approval No. | China NMPA H19980041 |
| Drug Standard Code | 86900375001834 |
| Manufacturer | Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. |
| Intended Use | For research use only, not for therapeutic use |
Clodronate Disodium Capsules Background & Mechanism
Clodronate disodium is a bisphosphonate that inhibits osteoclast-mediated bone resorption by binding to hydroxyapatite crystals in bone and inhibiting osteoclast activity. It is commonly used in research to study bone metabolism and osteoclast function.
Storage & Handling
Storage: Store in a cool, dry place, away from direct sunlight.
Handling: Use appropriate personal protective equipment (PPE) when handling capsules.
Stability: Refer to the manufacturer’s instructions for stability information.
Additional information
| Weight | 1.1 kg |
|---|---|
| Dimensions | 18 × 16 × 18 cm |
1 review for Clodronate Disodium Capsules
Related products
Pamidronate Disodium Injection
High-purity Pamidronate Disodium 15mg injectable solution, 10 vials per box. Manufactured by Chengdu Tiantai Shan Pharmaceutical Co., Ltd., it’s a nitrogen-containing bisphosphonate ideal for bone metabolism, osteoporosis, and oncology research. $1.00Elranatamab Injection
Elranatamab (ELREXFIO®) is a BCMA-CD3 bispecific antibody used in multiple myeloma research. Supplied as a 76mg/1.9mL single-dose vial, manufactured by Pfizer. Approved by FDA (Aug 2023) and EMA (Dec 2023). Ideal for oncology, immunotherapy, and Tcell engager studies.
$1.00Irinotecan Hydrochloride Liposome Injection
Irinotecan Hydrochloride Liposome Injection Du’EnYi® is China’s first domestically approved liposome-encapsulated irinotecan injection, equivalent to ONIVYDE®. Each 10mL vial contains 43mg irinotecan and is strictly for laboratory research use only—not for clinical or human application.Please consult the staff for other purposes. $1.00Temozolomide Capsules
Temozolomide 100mg capsules, 5 count box, produced by Shanghai ChuanNuo Pharmaceuticals Co., Ltd., approved under NMPA H20234716. A key alkylating agent for glioblastoma and astrocytoma research—ideal for preclinical oncology models. $1.00
deanper –
Thank you, I will buy it next time